SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Gross Caroline) srt2:(2010-2014)"

Sökning: WFRF:(Gross Caroline) > (2010-2014)

  • Resultat 1-5 av 5
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Bolton, Kelly L., et al. (författare)
  • Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
  • 2012
  • Ingår i: JAMA: The Journal of the American Medical Association. - : American Medical Association (AMA). - 1538-3598. ; 307:4, s. 382-390
  • Tidskriftsartikel (refereegranskat)abstract
    • Context Approximately 10% of women with invasive epithelial ovarian cancer (EOC) carry deleterious germline mutations in BRCA1 or BRCA2. A recent article suggested that BRCA2-related EOC was associated with an improved prognosis, but the effect of BRCA1 remains unclear. Objective To characterize the survival of BRCA carriers with EOC compared with noncarriers and to determine whether BRCA1 and BRCA2 carriers show similar survival patterns. Design, Setting, and Participants A pooled analysis of 26 observational studies on the survival of women with ovarian cancer, which included data from 1213 EOC cases with pathogenic germline mutations in BRCA1 (n=909) or BRCA2 (n=304) and from 2666 noncarriers recruited and followed up at variable times between 1987 and 2010 (the median year of diagnosis was 1998). Main Outcome Measure Five-year overall mortality. Results The 5-year overall survival was 36% (95% CI, 34%-38%) for noncarriers, 44% (95% CI, 40%-48%) for BRCA1 carriers, and 52% (95% CI, 46%-58%) for BRCA2 carriers. After adjusting for study and year of diagnosis, BRCA1 and BRCA2 mutation carriers showed a more favorable survival than noncarriers (for BRCA1: hazard ratio [HR], 0.78; 95% CI, 0.68-0.89; P<.001; and for BRCA2: HR, 0.61; 95% CI, 0.50-0.76; P<.001). These survival differences remained after additional adjustment for stage, grade, histology, and age at diagnosis (for BRCA1: HR, 0.73; 95% CI, 0.64-0.84; P<.001; and for BRCA2: HR, 0.49; 95% CI, 0.39-0.61; P<.001). The BRCA1 HR estimate was significantly different from the HR estimated in the adjusted model (P for heterogeneity=.003). Conclusion Among patients with invasive EOC, having a germline mutation in BRCA1 or BRCA2 was associated with improved 5-year overall survival. BRCA2 carriers had the best prognosis. JAMA. 2012;307(4):382-390
  •  
2.
  • Jacobs, Kevin B, et al. (författare)
  • Detectable clonal mosaicism and its relationship to aging and cancer.
  • 2012
  • Ingår i: Nature Genetics. - New York : Nature Publishing Group. - 1061-4036 .- 1546-1718. ; 44:6, s. 651-658
  • Tidskriftsartikel (refereegranskat)abstract
    • In an analysis of 31,717 cancer cases and 26,136 cancer-free controls from 13 genome-wide association studies, we observed large chromosomal abnormalities in a subset of clones in DNA obtained from blood or buccal samples. We observed mosaic abnormalities, either aneuploidy or copy-neutral loss of heterozygosity, of >2 Mb in size in autosomes of 517 individuals (0.89%), with abnormal cell proportions of between 7% and 95%. In cancer-free individuals, frequency increased with age, from 0.23% under 50 years to 1.91% between 75 and 79 years (P = 4.8 × 10(-8)). Mosaic abnormalities were more frequent in individuals with solid tumors (0.97% versus 0.74% in cancer-free individuals; odds ratio (OR) = 1.25; P = 0.016), with stronger association with cases who had DNA collected before diagnosis or treatment (OR = 1.45; P = 0.0005). Detectable mosaicism was also more common in individuals for whom DNA was collected at least 1 year before diagnosis with leukemia compared to cancer-free individuals (OR = 35.4; P = 3.8 × 10(-11)). These findings underscore the time-dependent nature of somatic events in the etiology of cancer and potentially other late-onset diseases.
  •  
3.
  • Karl, Matthias, et al. (författare)
  • A new flexible multicomponent model for the study of aerosol dynamics in the marine boundary layer
  • 2011
  • Ingår i: Tellus. Series B, Chemical and physical meteorology. - : Stockholm University Press. - 0280-6509 .- 1600-0889. ; 63:5, s. 1001-1025
  • Tidskriftsartikel (refereegranskat)abstract
    • A new sectional aerosol dynamics model, MAFOR, was developed with the focus to study nucleation in the marine boundary layer. Novel aspects of the model are (1) flexibility in the treatment of gas phase chemistry, (2) treatment of liquid phase chemistry, which can be extended according to needs and (3) simultaneous calculation of number and mass concentration distributions of a multicomponent aerosol as functions of time. Comparison with well-documented aerosol models (MONO32 and AEROFOR), a comprehensive data set on gas phase compounds, aerosol size distribution and chemical composition obtained during the AOE-96 (Arctic Ocean Expedition, 1996) was used to evaluate the model. Dimethyl sulphide decay during advection of an air parcel over the Arctic pack ice was well captured by the applied models and predicted concentrations of gaseous sulphuric acid and methane sulphonic acid range up to 1.0 x 10(6) cm(-3) and 1.8 x 10(6) cm(-3), respectively. Different nucleation schemes were implemented in MAFOR which allow the simulation of new particle formation. Modelled nucleation rates from sulphuric acid nucleation via cluster activation were up to 0.21 cm(-3) s(-1) while those from ion-mediated nucleation were below 10(-2) cm(-3) s(-1). Classical homogeneous binary and ternary nucleation theories failed to predict nucleation over the central Arctic Ocean in summer.
  •  
4.
  • Karl, Matthias, et al. (författare)
  • A study of new particle formation in the marine boundary layer over the central Arctic Ocean using a flexible multicomponent aerosol dynamic model
  • 2012
  • Ingår i: Tellus. Series B, Chemical and physical meteorology. - : Stockholm University Press. - 0280-6509 .- 1600-0889. ; 64, s. 17158-
  • Tidskriftsartikel (refereegranskat)abstract
    • Enhancement of number concentrations of particles with sizes less than 25 nm diameter has been frequently observed in the boundary layer over the central Arctic Ocean during summer. The sectional aerosol dynamics model for Marine Aerosol Formation (MAFOR) was applied to evaluate the capability of different nucleation mechanisms to reproduce nucleation events observed during three expeditions (1996, 2001 and 2008) onboard the Swedish icebreaker Oden. Model calculations suggest that a source rate of a condensable organic vapour (OV) of about 2 x 10(5) cm(-3) s(-1) is required to reproduce observed growth of nucleation mode particles. Nucleation rates predicted by the newly proposed combined sulphuric acid nucleation mechanism, which best described new particle formation in the Arctic, ranged from 0.04 to 0.1 cm(-3) s(-1). This mechanism additively combines ion-mediated nucleation and cluster activation, and treats condensation of OV without correction of the Kelvin effect. In several events, the simultaneous number enhancement of particles in the 20-50 nm size range remained unexplained by the nucleation mechanisms. This lends support to alternative theories such as the fragmentation of marine gels (approximate to 200-500 nm diameter in size) by physical or chemical processes.
  •  
5.
  • Lyons, Paul A, et al. (författare)
  • Genetically Distinct Subsets within ANCA-Associated Vasculitis
  • 2012
  • Ingår i: New England Journal of Medicine. - : Massachusetts Medical Society. - 0028-4793 .- 1533-4406. ; 367:3, s. 214-223
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND less thanbrgreater than less thanbrgreater thanAntineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a severe condition encompassing two major syndromes: granulomatosis with polyangiitis (formerly known as Wegeners granulomatosis) and microscopic polyangiitis. Its cause is unknown, and there is debate about whether it is a single disease entity and what role ANCA plays in its pathogenesis. We investigated its genetic basis. less thanbrgreater than less thanbrgreater thanMETHODS less thanbrgreater than less thanbrgreater thanA genomewide association study was performed in a discovery cohort of 1233 U. K. patients with ANCA-associated vasculitis and 5884 controls and was replicated in 1454 Northern European case patients and 1666 controls. Quality control, population stratification, and statistical analyses were performed according to standard criteria. less thanbrgreater than less thanbrgreater thanRESULTS less thanbrgreater than less thanbrgreater thanWe found both major-histocompatibility-complex (MHC) and non-MHC associations with ANCA-associated vasculitis and also that granulomatosis with polyangiitis and microscopic polyangiitis were genetically distinct. The strongest genetic associations were with the antigenic specificity of ANCA, not with the clinical syndrome. Anti-proteinase 3 ANCA was associated with HLA-DP and the genes encoding alpha(1)-antitrypsin (SERPINA1) and proteinase 3 (PRTN3) (P = 6.2x10(-89), P = 5.6x10(-12), and P = 2.6x10(-7), respectively). Anti-myeloperoxidase ANCA was associated with HLA-DQ (P = 2.1x10(-8)). less thanbrgreater than less thanbrgreater thanCONCLUSIONS less thanbrgreater than less thanbrgreater thanThis study confirms that the pathogenesis of ANCA-associated vasculitis has a genetic component, shows genetic distinctions between granulomatosis with polyangiitis and microscopic polyangiitis that are associated with ANCA specificity, and suggests that the response against the autoantigen proteinase 3 is a central pathogenic feature of proteinase 3 ANCA-associated vasculitis. These data provide preliminary support for the concept that proteinase 3 ANCA-associated vasculitis and myeloperoxidase ANCA-associated vasculitis are distinct autoimmune syndromes. (Funded by the British Heart Foundation and others.)
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-5 av 5

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy